Peng Yuan

ORCID: 0000-0002-5041-5613 · 8 papers in corpus
lab-animal 2026
EBioMedicine ·doi:10.1016/j.ebiom.2026.106306

BACKGROUND: Hydrosalpinx affects 10-30% of infertile women, creating a hostile tubal microenvironment that impairs embryonic development. Although fluid embryotoxicity is recognised, specific toxic metabolites and their molecular mechanisms…

lab-animal 2025
Current pharmaceutical biotechnology ·doi:10.2174/0113892010331129250216041033

AIMS: The present study aimed to examine the roles of circRNA-circSMAD2 and its regulatory mechanisms in endometriosis (EMs). BACKGROUND: Evidence has confirmed that circRNAs play multiple roles in regulating the occurrence and development…

lab-animal 2024
Genomics ·doi:10.1016/j.ygeno.2024.110803

N6-methyladenosine (m6A) methylation is the most prevalent internal epigenetic posttranscriptional mechanism for regulating mammalian RNA. Despite recent advances in determining the biological functions of m6A methylation, its association w…

lab-animal 2023
Biology of reproduction ·doi:10.1093/biolre/ioad057

Endometriosis is a chronic inflammatory disease distinguished by ectopic endometrium and fibrosis. NLRP3 inflammasome and pyroptosis are present in endometriosis. Aberrant increase of Long noncoding (Lnc)-metastasis-associated lung adenocar…

lab-animal 2021
Biology of reproduction ·doi:10.1093/biolre/ioab152

N 6-methyladenosine (m6A), one of the most abundant RNA modifications, is involved in the progression of many diseases, but its role and related molecular mechanisms in endometriosis remain unknown. To address these issues, we detected m6A …

lab-animal 2012
Human Reproduction ·doi:10.1093/humrep/des142

BACKGROUND: A previous study demonstrated that local application of levonorgestrel-loaded polylactic acid microspheres (LNG microspheres) resulted in significant regression of endometriotic cysts in a rabbit model for 6 months without distu…

other 2009
Medical hypotheses ·doi:10.1016/j.mehy.2009.08.001

As a common cause of chronic pelvic pain, endometriosis affects 10% of women of reproductive age. The most popular strategy for treating endometriosis is pseudo-pregnancy therapy. However, the efficacy of common systemic pseudo-pregnancy th…

lab-animal 2009
Human Reproduction ·doi:10.1093/humrep/dep386

BACKGROUND: Endometriosis is a chronic disease that responds to systemic pseudo-pregnancy therapy. However, side effects limit their long-term use, and recurrence often occurs after cessation of medication. Reducing side effects whereas imp…